Hyperkalemia Clinical Trials

102 clinical trials for Hyperkalemia across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age — RECRUITING · PHASE2
• Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil — RECRUITING
• Lower vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency Department — RECRUITING · NA
• Adding Urea to the Final Dialysis Fluid — RECRUITING · PHASE1
• Dietary Potassium Liberalization in Pre-Dialysis Patients — RECRUITING · NA
• Potassium Correction for RAAS Optimization in Chronic Kidney Disease — RECRUITING · PHASE4
• A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia — RECRUITING · PHASE3
• AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring — RECRUITING
• Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community — RECRUITING
• COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable — RECRUITING
• Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes — RECRUITING
• AN OPEN-LABEL STUDY TO ASSESS SAFETY AND EFFICACY OF SZC IN PAEDIATRIC PATIENTS WITH HYPERKALAEMIA — RECRUITING
• A PHASE 2, OPEN-LABEL, MULTIPLE DOSE STUDY TO EVALUATE THE PHARMACODYNAMIC EFFECTS, SAFETY AND TOLERABILITY OF PATIROMER FOR ORAL SUSPENSION IN CHILDREN AND ADOLESCENTS 2 TO < 18 YEARS OF AGE WITH CHRONIC KIDNEY DISEASE AND HYPERKALEMIA (EMERALD) — RECRUITING · PHASE2
• Potassium Supplementation in CKD — ACTIVE_NOT_RECRUITING · NA
• Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study — NOT_YET_RECRUITING · NA
• Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia — COMPLETED · PHASE4
• Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study — NOT_YET_RECRUITING · PHASE4
• Hyperkalemia Quality Improvement Program (HK-QIP) Study — ACTIVE_NOT_RECRUITING · NA
• Lokelma for RAAS Maximisation in CKD & Heart Failure. — COMPLETED · PHASE3
• Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects — COMPLETED · PHASE3
• Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG — COMPLETED
• InSaKa trial: Insulin dextrose infusion versus nebulized salbutamol versus combination of salbutamol and insulin dextrose in acute hyperkalemia: a randomized clinical trial — OTHER · PHASE4
• A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia — TERMINATED · PHASE3
• IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors — WITHDRAWN
• 5 Versus 10 Units of Insulin in Hyperkalemia Management — COMPLETED · PHASE4
• Nurse-Led Nutritional Education for Moroccan Dialysis Patients — COMPLETED · NA
• An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure — COMPLETED
• Tracking Treatment Pathways in Adult Patients With Hyperkalemia. — COMPLETED
• OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure — ACTIVE_NOT_RECRUITING · PHASE2
• Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes) — TERMINATED · PHASE3
• The ORTIZ Study: Optimising RASi Therapy With SZC — TERMINATED · PHASE2
• Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients — COMPLETED · PHASE4
• A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia. — COMPLETED · PHASE3
• Targeted Potassium Levels for Prevention of ICD Therapy — ACTIVE_NOT_RECRUITING · PHASE4
• Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients — COMPLETED
• Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4 — OTHER · PHASE4
• SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients — COMPLETED · NA
• the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients — NOT_YET_RECRUITING · PHASE4
• Patiromer Trial in CKD Stage IIIB to V — TERMINATED · PHASE3
• Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia — COMPLETED
• Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE) — COMPLETED · NA
• A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia — COMPLETED · PHASE4
• The Safety and Tolerability of WS016 in Healthy Chinese Volunteers — COMPLETED · PHASE1
• A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia. — OTHER · PHASE2
• A Multicenter Study to Evaluate the Nutritional Suitability of Renastart — COMPLETED · NA
• Early Protein Supplementation on Prevention of Hyperkalemia — COMPLETED · NA
• Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management — TERMINATED · PHASE4
• A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG) — COMPLETED
• Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels — COMPLETED
• Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis — COMPLETED

Refine this search